Aravind Paramasivan is a seasoned QA professional specializing in GCP audits and quality compliance support across clinical development phases. They previously served as the Clinical Compound Quality Program Manager at Takeda from 2014 to 2017 and as R&D QA Manager at Shire from 2011 to 2014. Currently, Aravind is the Director of GCP Audits at Gilead Sciences, where they oversee audit management. They hold a Master of Science in Clinical Pharmacology from the University of Aberdeen, earned in 2005.
This person is not in the org chart
This person is not in any teams
This person is not in any offices